Patient outcomes in schizophrenia II: The impact of cognition

European Psychiatry

Volumn 20, Issue 5-6, 2005, Pages 395-402

  Hofer, Alex ^a   Baumgartner, Susanne ^a   Bodner, Thomas ^a   Edlinger, Monika ^a   Hummer, Martina ^a   Kemmler, Georg ^a   Rettenbacher, Maria A ^a   Fleischhacker, W Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cognition; Employment; Needs; Outcome; Quality of life; Schizophrenia

Indexed keywords

CLOZAPINE; OLANZAPINE;

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; OCCUPATION; OUTCOMES RESEARCH; OUTPATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL DISABILITY; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; VISUAL MEMORY; WORKING MEMORY;

ADULT; AGE FACTORS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CLOZAPINE; COGNITION; COGNITION DISORDERS; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; OUTPATIENTS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 24944542801     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.02.006     Document Type: Article

References (39)

1. J. Addington, and D. Addington Neurocognitive and social functioning in schizophrenia Schizophr. Bull. 25 1999 173 182
2. S. Aschenberger, O. Tucher, and K.W. Lange Regensburger Wörtflüssigkeits-Test. 2000 Hogrefe Verlag für Psychologie Göttingen
3. A.S. Benton, and O. Spreen Der Benton Test. Handbuch: 7 1996 Auflage
4. J.S. Brekke, S. Levin, G. Wolkon, G. Sobel, and B. Slade Psychosocial functioning and subjective experience in schizophrenia Schizophr. Bull. 19 1993 599 608
5. J.S. Brekke, B. Kohrt, and M.F. Green Neuropsychological functioning as a moderator of the relationship between psychosocial functioning and the subjective experience of self and life in schizophrenia Schizophr. Bull. 27 2001 697 708
6. S. Browne, M. Roe, A. Lane, M. Gervin, M. Morris, and A. Kinsella Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology, and tardive dyskinesia Acta Psychiatr. Scand. 94 1996 118 124
7. P.W. Corrigan, R.R. Reinke, S.A. Landsberger, A. Charate, and G.A. Toombs The effects of atypical antipsychotic medications on psychosocial outcomes Schizophr. Res. 63 2003 97 101
8. D.C. Delis, J.H. Kramer, E. Kaplan, and B.A. Ober California verbal learning and memory test (Manual) 1987 Psychological Corporation San Antonio, TX
9. W.R. Dillon, and M. Goldstein Multivariate analysis. Methods and applications 1984 Wiley New York
10. W.W. Fleischhacker Pharmacological treatment of schizophrenia: a review M. Maj N. Sartorius Schizophrenia. WPA Series evidence and experience in psychiatry 2002 Wiley Chichester, NY, Weinheim, Brisbane, Singapore, Toronto 75 113
11. M.F. Green What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153 1996 321 330
12. M.F. Green, R.S. Kern, D.L. Braff, and J. Mintz Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr. Bull. 26 2000 119 136
13. S.H. Hamilton, E.T. Edgell, D.A. Revicki, and A. Breier Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample Clin. Psychopharmacol. 15 2000 245 255
14. P.D. Harvey, M.F. Green, R.S.E. Keefe, and D.I. Velligan Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness J. Clin. Psychiatry 65 2004 361 372
15. R.K. Heaton, G.J. Chelune, J.L. Taley, G.G. Kay, and G. Curtiss Wisconsin Card Sorting Test manual: revised and expanded 1993 Psychological Assessment Resources Odessa, FL
16. A. Hofer, G. Kemmler, U. Eder, M. Edlinger, M. Hummer, and W.W. Fleischhacker Quality of life in schizophrenia: the impact of psychopathology, drug attitude and side effects J. Clin. Psychiatry 65 2004 932 939
17. A. Hofer, S. Baumgartner, M. Edlinger, M. Hummer, G. Kemmler, and M.A. Rettenbacher Patient outcomes in schizophrenia I: the impact of sociodemographic variables, psychopathology, and side effects Eur Psychiatry 20 2005 (in press)
18. A. Karow, and D. Naber Subjective well-being and quality of life under atypical antipsychotic treatment Psychopharmacology (Berlin) 162 2002 3 10
19. S.R. Kay, A. Fiszbein, and L.A. Opler The Positive and Negative Syndrome Scale (PANSS) for schizophrenia Schizophr. Bull. 13 1987 261 276
20. G. Kemmler, B. Holzner, C. Neudorfer, U. Meise, and H. Hinterhuber General life satisfaction and domain-specific quality of life in chronic schizophrenic patients Qual. Life Res. 6 1997 265 273
21. S. Landau, and B.S. Everitt A handbook of statistical analyses using SPSS 2004 Chapman and Hall London
22. S. Lehrl Manual zum MWT-B 1977 Verlag Dr. med. D. Straube Erlangen
23. A. Leung, and P. Chue Sex differences in schizophrenia, a review of the literature Acta Psychiatr. Scand. 101 2000 3 38
24. J.P. Lindenmayer, R. Bernstein-Hyman, and S. Grochowski Five-factor model of schizophrenia J. Nerv. Ment. Dis. 182 1994 631 638
25. J.P. Lindenmayer, S. Grochowski, and R.B. Hyman Five factor model of schizophrenia: replication across samples Schizophr. Res. 14 1995 229 234
26. K.H. Littrell, R.G. Petty, N.M. Hilligoss, C.D. Kirshner, and C.G. Johnson Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine Schizophr. Res. 66 2004 201 202
27. S. McGurk, P.J. Moriarty, P.D. Harvey, M. Parrella, L. White, and K.L. Davis The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia Schizophr. Res. 42 2000 47 55
28. S. Priebe, M. Heinze, and A. Jäkel Berliner Bedürfnisinventar (BeBI) 1993 Abteilung für Sozialpsychiatrie, FU Berlin
29. M.V. Rempfer, E.K. Hamera, C.E. Brown, and R.L. Cromwell The relations between cognition and the independent living skill of shopping in people with schizophrenia Psychiatry Res. 117 2003 103 112
30. N. Sartorius, W.W. Fleischhacker, U. Gjerris, U. Kern, M. Knapp, and B.E. Leonard The usefulness and use of second generation antipsychotic medications-an update Curr. Opin. Psychiatry 16 Suppl 1 2003 1 44
31. T. Sharma, and L. Antonova Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment Psychiatr. Clin. North Am. 26 2003 25 40
32. T. Sharma, C. Hughes, W. Soni, and V. Kumari Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia Psychopharmacology (Berlin) 169 2003 398 403
33. M. Slade, G. Thornicroft, L. Loftus, M. Phelan, and T. Wykes CAN: Camberwell Assessment of Need Scales 1999 Gaskell London
34. The WHOQOL Group Development of the World Health Organization WHOQOL-BREF quality of life assessment Psychol. Med. 28 1998 551 558
35. D.I. Velligan, R.K. Mahurin, P.L. Diamond, B.C. Hazleton, S.L. Eckert, and A.L. Miller The functional significance of symptomatology and cognitive function in schizophrenia Schizophr. Res. 25 1997 21 31
36. D.I. Velligan, C.C. Bow-Thomas, R.K. Mahurin, A.L. Miller, and L.C. Halgunseth Do specific neurocognitive deficits predict specific domains of community function in schizophrenia? J. Nerv. Ment. Dis. 188 2000 518 524
37. P. Weiden, and J. Mackell Lecture held at the 152nd Annual Meeting of the APA, Washington, DC 1999 May 15-20
38. E.M. Weiss, R.M. Bilder, and W.W. Fleischhacker The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia Psychopharmacology (Berlin) 162 2002 11 17
39. P. Zimmermann, and B. Fimm Testbatterie zur Aufmerksamkeitsprüfung (TAP), Version 1.7. Herzogenrath: Vera Fimm/Psychologische Testsysteme 2002